New drug FT1 tested for safety in healthy volunteers
NCT ID NCT06610487
First seen Mar 07, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This early-stage study tested whether FT1 is safe in 60 healthy adults aged 18 to 45. Participants received one or more injections of FT1 or a placebo. Researchers monitored side effects and measured how the drug behaves in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA CAUSED BY DRUG (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 402760, China
Conditions
Explore the condition pages connected to this study.